ProPhase Labs Seeks Director Amidst Nasdaq Compliance Issue

The latest update is out from Prophase Labs ( (PRPH) ).

ProPhase Labs, Inc. has fallen out of compliance with Nasdaq’s audit committee requirements due to an unexpected vacancy prompted by the resignation of Eleanor McBrier from the company’s Board of Directors. Her departure was amicable, attributed to policy conflicts with her employer, not to disputes with ProPhase. The company is actively seeking a new director with expertise in gastroenterology to aid in the development of their esophageal cancer test, underscoring their commitment to corporate governance and innovation in medical diagnostics.

See more data about PRPH stock on TipRanks’ Stock Analysis page.